Beijing Shengguangna Medical Technology

Beijing Shengguangna Medical Technology is a specialized biotechnology and medical device company focused on the development of magnetic hyperthermia therapy (MHT) for cancer treatment. The company's core technology involves the use of superparamagnetic iron oxide nanoparticles that are injected into tumor tissue and subsequently activated by an external alternating magnetic field to generate localized heat. This process induces thermal ablation and apoptosis in cancer cells while minimizing damage to surrounding healthy tissues. Shengguangna is a pioneer in the clinical translation of nanotechnology-based thermal therapies in China, targeting difficult-to-treat malignancies such as glioblastoma. Their integrated approach combines advanced nanomaterials with proprietary magnetic field induction hardware to provide a next-generation oncology solution.